Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Kansas State University researchers identify nucleoside transport inhibitor TT-24

Aug. 28, 2002

ABI-007, a new cremophor-free nanoparticle formulation of paclitaxel

Aug. 28, 2002

Boehringer Ingelheim claims telomerase-inhibiting carboxamides

Aug. 27, 2002

SGN-15 enters phase II in advanced ovarian cancer

Aug. 27, 2002

Gleevec granted priority review for first-line use in early CML

Aug. 27, 2002

Oncogene BRAF is mutated in a high proportion of human melanomas

Aug. 27, 2002

Xcytrin to enter new phase III trial in NSCLC patients

Aug. 26, 2002

Novel HDAC inhibitors in early development at Roche

Aug. 23, 2002

STO-609, a potent and selective CaM-KK inhibitor synthesized at Sumitomo

Aug. 23, 2002

ZYC-101a shows potential in the treatment of anal dysplasia

Aug. 22, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.